The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.00
Bid: 108.00
Ask: 109.00
Change: -1.50 (-1.37%)
Spread: 1.00 (0.926%)
Open: 109.50
High: 110.00
Low: 108.00
Prev. Close: 109.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

November 2020 Trading and Regulatory Update

17 Dec 2020 07:00

RNS Number : 9234I
International Personal Finance Plc
17 December 2020
 

17 December 2020

International Personal Finance plc

November 2020 Trading and Regulatory Update

 

International Personal Finance plc (IPF) specialises in providing unsecured consumer credit to around 1.7 million customers across 10 markets. We operate the world's largest home credit business and a leading fintech business, IPF Digital.

 

As part of our ongoing strategy to regularly inform and update investors on key operational performance metrics during the Covid-19 pandemic, IPF is publishing the following information for November 2020 together with an update on regulatory matters.

 

· Robust collections effectiveness

Collections effectiveness was robust in November and remains at 97% of pre-Covid expectations. All of our businesses (excluding Hungary where an opt-out moratorium is in place) delivered a good performance. The modest reduction in collections effectiveness we expected during the winter has not materialised, but we continue to plan for a softening in performance in the coming months.

 

· Credit issued stable

Although most of our markets are currently implementing more restrictive measures on people movements to cope with the second wave of the Covid-19 pandemic, credit issued increased by 1 ppt in the month to 61% of pre-Covid expectations. We have progressively relaxed credit settings since the half year and our plan remains focused on rebuilding the receivables portfolio while maintaining a clear focus on portfolio quality and the macroeconomic effects of Covid.

 

· Regulatory update

Following its actions earlier in 2020 in response to the pandemic, the Polish government is proposing a bundle of further measures, including the extension from 8 March 2021 until the end of 2021 of the temporarily reduced cap on non-interest costs of consumer credit. The proposals, which would only impact new lending, are expected to be debated in the Polish houses of parliament in the coming weeks and may also be referred to the EU for review and comment. We will update the market with our assessment of the potential financial impact on our Polish business, if and when the proposals are finalised and enacted.

 

 

Gerard Ryan, CEO at IPF, commented: "We continued to perform well in November. Collections remained robust and we increased credit issued in line with our strategy to progressively rebuild the receivables portfolio while maintaining credit quality. We will continue to focus on protecting our colleagues so they can serve our customers safely during the peak month of December and beyond."

 

Investor relations and media contact:

International Personal Finance

Rachel Moran

+44 (0)7760 167637 / +44 (0)113 285 6798

 

A copy of this statement can be found on our website - www.ipfin.co.uk

 

 

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKABBFBDDOBD
Date   Source Headline
2nd May 20241:53 pmRNSResults of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20246:01 pmRNSBoard Committee Membership Changes
1st May 20246:00 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.